$INO It is funny how many bulls are on this with no real success news and a pending law suite to fight off! June 26, 2020 05:53 AM ET (BZ Newswire) -- News Stifel analyst Stephen Willey downgrades Inovio Pharmaceuticals (NASDAQ:INO) from Buy to Hold and raises the price target from $19 to $24.
  • 2